Experienced in Spasticity

Tanya Gurevich

6 Weizmann Street, 6423906, 
Tel Aviv, TA, IL 
Experienced in Spasticity
6 Weizmann Street, 6423906, 
Tel Aviv, TA, IL 
OverviewLocationsClinical Research

Overview

Tanya Gurevich practices in Tel Aviv, Israel. Ms. Gurevich is rated as an Experienced expert by MediFind in the treatment of Spasticity. Her top areas of expertise are Movement Disorders, Parkinson's Disease, Multiple System Atrophy, Familial Dysautonomia, and Deep Brain Stimulation.

Her clinical research consists of co-authoring 135 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Spasticity.

Gender
Female

Locations

6 Weizmann Street, 6423906, Tel Aviv, TA 64239, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Multicenter, Randomized, Active-controlled, Double-blind, Double-dummy, Parallel-group Clinical Trial, Investigating the Efficacy, Safety, and Tolerability of Continuous Subcutaneous ND0612 Infusion in Comparison to Oral IR-LD/CD in Subjects With Parkinson's Disease Experiencing Motor Fluctuations (BouNDless)
A Multicenter, Randomized, Active-controlled, Double-blind, Double-dummy, Parallel-group Clinical Trial, Investigating the Efficacy, Safety, and Tolerability of Continuous Subcutaneous ND0612 Infusion in Comparison to Oral IR-LD/CD in Subjects With Parkinson's Disease Experiencing Motor Fluctuations (BouNDless)
Enrollment Status: Active_not_recruiting
Publish Date: May 21, 2025
Intervention Type: Drug, Combination product
Study Drugs: ND0612 Solution, Carbidopa, Levodopa
Study Phase: Phase 3
A Phase 1, Blinded, Randomized, Placebo-controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of BIIB132 Administered Intrathecally to Adults With Spinocerebellar Ataxia 3
A Phase 1, Blinded, Randomized, Placebo-controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of BIIB132 Administered Intrathecally to Adults With Spinocerebellar Ataxia 3
Enrollment Status: Terminated
Publish Date: August 04, 2023
Intervention Type: Drug
Study Drug: BIIB132
Study Phase: Phase 1
Parkinson's Foundation Quality Improvement Initiative
Parkinson's Foundation Quality Improvement Initiative
Enrollment Status: Completed
Publish Date: July 14, 2023
PDx Biomarker Assay Study for the Diagnosis of Parkinson's Disease
PDx Biomarker Assay Study for the Diagnosis of Parkinson's Disease
Enrollment Status: Unknown
Publish Date: July 10, 2018
View 3 Less Clinical Trials

135 Total Publications

Genetic testing for Parkinson's disease in Israel: Insights from the Rostock Parkinson's Disease (ROPAD) study.
Genetic testing for Parkinson's disease in Israel: Insights from the Rostock Parkinson's Disease (ROPAD) study.
Journal: Parkinsonism & related disorders
Published: March 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Gurevich's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 19 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile